Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections

Journal of Rheumatology

Volumn 24, Issue 11, 1997, Pages 2153-2157

  Euler, Hans H ^a,b   Harten, Pontus ^a   Zeuner, Rainald A ^a   Schwab, Ulrich M ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Dept of Int Med and Rheumatology ^*  (Germany)

Author keywords

Granulocyte colony stimulating factor; Neutropenia; Systemic lupus erythematosus

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INFECTION; INFECTION RISK; LEUKOCYTE COUNT; LEUKOCYTOCLASTIC VASCULITIS; MALE; NEUTROPENIA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; INFECTION; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; RECOMBINANT PROTEINS;

EID: 0030710963     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
2. Boumpas DT, Austin HA 3rd, Fessler BJ, Balow JE, Klippel JH, Lockshin MD: Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995;122:940-50.
3. Antolin J, Amerigo MJ, Gomez E, Acosta A, Martin JM, Cardenes MA: The hematological manifestations in 111 patients with systemic lupus erythematosus. Ann Med Interna 1991;8:170-3.
4. Nossent JC, Swaak AJ: Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med 1991;80:605-12.
5. Keeling DM, Isenberg DA: Haematological manifestations of systemic lupus erythematosus. Blood Rev 1993;7:199-207.
6. Stahl NI, Klippel JH, Decker JL: Fever in systemic lupus erythematosus. Am J Med 1979;67:935-40.
7. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M: Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978;21:37-44.
8. Arenas M, Abad A, Valverde V, Ferriz P, Pascual R: Selective inhibition of granulopoiesis with severe neutropenia in systemic lupus erythematosus. Arthritis Rheum 1992;35:979-80.
9. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 1994;31:1784-94.
10. Euler HH, Schwab UM, Schroeder JO: Filgrastim for lupus neutropenia (letter). Lancet 1994;344:1513-4.
11. Coon WW: Splenectomy for cytopenias associated with systemic lupus erythematosus. Am J Surg 1988;155:391-4.
12. Frampton JE, Lee CR, Faulds D: Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 1994;48:731-60.
13. Graham KE, Coodley GO: A prolonged use of granulocyte colony stimulating factor on Felty's syndrome. J Rheumatol 1995;22:174-6.
14. Dale DC: Hematopoietic growth factors for the treatment of severe chronic neutropenia. Stem Cells (Dayt) 1995;13:94-100.
15. Kondo H, Dale Y, Sakai Y, Akimoto M: Effective simultaneous rhG-CSF and methylprednisolone "pulse" therapy in agranulocytosis associated with systemic lupus erythematosus. Am J Hematol 1994;46:157-8.
16. Liang MH, Fortin PR, Isenberg DA, Snaith L: Quantitative clinical assessment of disease activity in systemic lupus erythematosus: Progress report and research agenda. Rheumatol Int 1991;11:133-6.
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
18. Rosenthal NS, Farhi DC: Bone marrow findings in connective tissue disease. Am J Clin Pathol 1989;92:650-4.
19. Feng CS, Ng MH, Szeto RS, Li EK: Bone marrow findings in lupus patients with pancytopenia. Pathology 1991;23:5-7.
20. Lorand-Metze I, Carvalho MA, Costallat LT: Morphology of bone marrow in systemic lupus erythematosus. Pathologe 1994;15:292-6.
21. Borba EF, Pereira RM, Velloso ED, Pereira IA, Goncalves CR, Yoshinari NH: Neutropenia associated with myelofibrosis in systemic lupus erythematosus. Acta Haematol 1993;89:82-5.
22. Nanji AA, Jetha N: Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus. J Clin Pathol 1984;37:714.
23. el Mouzan MI, Ahmad MA, al Fadel Saleh M, al Sohaibani MO, al Gindan YM: Myelofibrosis and pancytopenia in systemic lupus erythematosus. Acta Haematol 1988;80:219-21.
24. Fukuya H, Hirose W, Masuda T, Kawai T, Watanabe K, Kawagoe M: A case of systemic lupus erythematosus presenting with myelofibrosis as a cause of pancytopenia. Ryumachi 1994;34:773-8.
25. Liu H, Ozaki K, Matsuzaki Y, Abe M, Kosaka M, Saito S: Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 1995;100:480-5.
26. Drew SI, Terasaki PI: Autoimmune cytotoxic granulocyte antibodies in normal persons and various diseases. Blood 1978;52:941-52.
27. Minchinton RM, Waters AH: The occurrence and significance of neutrophil antibodies. Br J Haematol 1984;56:521-8.
28. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P: Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996;334:630-3.
29. Dong F, Hoefsloot LH, Schelen AM, et al: Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA 1994;91:4480-4.
30. Guba SC, Sartor CA, Hutchinson R, Boxer LA, Emerson SG: Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia. Blood 1994;83:1486-92.
31. Mempel K, Pietsch T, Menzel T, Zeidler C, Welte K: Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 1991;77:1919-22.
32. Mizuno Y, Hara T, Nagata M, et al: Serum granulocyte colony-stimulating factor levels in chronic neutropenia of infancy. Pediatr Hematol Oncol 1990;7:377-81.
33. Gudi R, Krishnamurthy M, Pachter BR: Astemizole in the treatment of granulocyte colony-stimulating factor-induced bone pain. Ann Intern Med 1995;123:236-7.
34. Hofmann M, Mahlke M, Casper F, Brockerhoff P: Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma. Zentralbl Gynakol 1995;117:314-6.
35. Comer M, Bucknall RC: Digital vasculitis after splenectomy in a patient with Felty's syndrome. Ann Rheum Dis 1992;51:908-9.
36. Johnson ML, Grimwood RE: Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994;130:77-81.
37. Couderc LJ, Philippe B, Franck N, Balloul-Delclaux E, Lessana-Leibowitch M: Necrotizing vasculitis and exacerbation of psoriasis after granulocyte colony-stimulating factor for small cell lung carcinoma. Respir Med 1995;89:237-8.
38. Vidarsson B, Geirsson AJ, Onundarson PT: Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome. Am J Med 1995;98:589-91.
39. Bonilla MA, Dale D, Zeidler C, et al: Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 1994;88:723-30.
40. Jain KK: Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 1994;31:213-5.
41. Yang YM, Mankad VN, Manci E: Granulocyte colony-stimulating factor associated leukocytoclastic vasculitis mimicking Henoch-Schonlein purpura. Pediatr Hematol Oncol 1993;10:193-5.
42. Schliesser G, Pralle H, Lohmeyer J: Leukocytoclastic vasculitis complicating G-CSF induced neutrophil recovery in T gamma-lymphocytosis with severe neutropenia. Ann Hematol 1992;65:151-2.
43. Nomiyama J, Shinohara K, Inoue H: Erythema nodosum caused by the administration of granulocyte colony-stimulating factor in a patient wilh refractory anemia. Am J Hematol 1994;47:333.
44. Via CS, Allen RC, Welton RC: Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: A relationship to disease activity. J Rheumatol 1984;11:745-53.
45. Farhey YD, Herman JH: Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome. J Rheumatol 1995;22:1179-82.
46. Teske E, Harten P, Schroeder JO, Euler HH: G-CSF following pulse cyclophosphamide in SLE (abstr). Arthritis Rheum 1992;(suppl)35:152.
47. Pixley JS, Yoneda KY, Manalo PB: Sequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in Felty's syndrome. Am J Hematol 1993;43:304-6.
48. Meropol NJ, Miller LL, Korn EL, Braitman LE, MacDermott ML, Schuchler LM: Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst 1992;84:1201-3.